4536 — Santen Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Santen Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	—	—	—	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	84,307	58,677	94,961	93,994	83,350
Net Total Accounts Receivable
Net Total Receivables	99,591	107,225	90,539	72,083	71,830
Total Inventory
Total Other Current Assets
Total Current Assets	229,426	213,326	236,139	224,300	228,758
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	56,287	66,173	71,576	72,954	78,115
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	459,976	421,179	435,699	409,277	423,033
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95,821	89,504	92,796	86,837	87,868
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	122,487	127,199	129,645	123,035	126,044
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	337,489	293,980	306,054	286,242	296,989
Total Liabilities & Shareholders' Equity	459,976	421,179	435,699	409,277	423,033
Total Common Shares Outstanding